CYTOKINES IN THE DIAGNOSIS OF THE SEVERITY OF THE ACTIVE PHASE OF CHRONIC PYELONEPHRITIS
https://doi.org/10.21886/2308-6424-2017-5-3-14-21
Abstract
Introduction. cytokines may serve as markers of the inflammatory process during exacerbation (i.w. active phase) and further progression of chronic pyelonephritis. The estimation of cytokine constellation in this field is important problem of clinical nephrology. Purpose of the study. the aim of the study was to evaluate the severity of chronic pyelonephritis during its exacerbation by measurement of cytokines concentration in urinalysis. Materials and methods. In 64 patients with active phase of chronic pyelonephritis at the age of 25 to 65 years, the results of the study of the content of proinflammatory (iL-1β, iL-6, iL-8, TNFα, iFNγ) and anti-inflammatory (iL-2, iL-4, iL- 10) cytokines in urine taken from the ureter, bladder and blood plasma to determine the severity of exacerbation of chronic pyelonephritis. Results. The level of proinflammatory cytokine iL-8 in urine from the ureter of the affected kidney can serve as the main marker determining the severity of the active phase of chronic pyelonephritis. With a mild degree of exacerbation of the inflammatory process, the content of iL-8 in urine from the ureter is 4 times higher than normal values; at an average degree - in 8 times, and at a serious current of an exacerbation of a chronic pyelonephritis - in 54 times. Conclusions. Determination of proinflammatory cytokines in the diagnosis of the severity of pyelonephritis flow has a large diagnostic and differential diagnostic significance that will allow for differentiated therapy depending on the severity of the inflammatory process and improve the results of treatment.
About the Authors
D. G. Korenkov
North-Western State Medical University named after I.I. Metchnikoff.
Russian Federation
Russian Federation
Dmitriy Georgievich Korenkov, doctor of medical science, professor Department of Urology Mechnikov North-West State Medical University.
St.-Petersburg.
A. L. Pavlov
Aleksandrovskaya hospital.
Russian Federation
Russian Federation
Anton Leonidovich, urologist, Urology Unit, Aleksandrovskaya Hospital.
St.-Petersburg.
References
1. Bryukhovetskii AG. Pielonefrity. Diagnos ka i lechenie vnutrennikh boleznei. Pod. red. akademika Komorova FI. M.; 1991:283-293. (in Russ.)
2. Rumyantsev ASh., Goncharova NS. E ologiya i patogenez pielonefrita. Nefrologiya. 2000;4(3):40-52. (In Russ.)
3. Tik nskii OL, Kalinina SN. Pielonefrity. SPb.: SPbMAPO; 1996:1-238. (In Russ.)
4. Nurtudinova GM. Urovni provospalitel’nykh tsitokinov u bol’nykh khronicheskim pielonefritom i ikh izmeneniya pri kompleksnoi terapii s primeneniem immunomodulyatora likopida [disserta on]. Ufa; 2003. (In Russ.)
5. Mukhin NA. Tarasova IE., Shilov E.M. Diagnos ka i lechenie boleznei pochek. M.; 2002:1-381. (In Russ.)
6. Koryakova NN, Rozhdestvenskaya ED, Kazantseva SV, Bushueva TV, Valamina IE. Features of a cytokine profile in patients with chronic giomerulonephritis with progressive chronic renal failure. Terapevticheskii arkhiv. 2006;78(5):14-17. (In Russ.)
7. Kudryasheva IP, Ospel’nikova TP, Ershov FI. Dinamika pokazatelei tsitokinovogo profi lya pri khronicheskom pielonefrite. Klinicheskaya nefrologiya. 2012;4:39-41. (In Russ.)
8. Sheu JN, Chen MC, Lue KH, Cheng SL, Lee IC, Chen SM, Tsay GJ. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5-6):276-82. doi: 10.1016/j. cyto.2007.02.006
9. Sheu JN, Chen SM, Meng MH, Lue KH. The role of serum and urine interleukin-8 on acute pyelonephritis and subsequent renal scarring in children. Pediatr Infect Dis J. 2009;28(10):885-90. doi: 10.1097/ INF.0b013e3181a39e23
10. Renata Y, Jassar H, Katz R, Hochberg A, Nir RR, KleinKremer A. Urinary concentration of cytokines in children with acute pyelonephritis. Eur J Pediatr. 2013;172(6):76974. doi: 10.1007/s00431-012-1914-2
11. Mayansky AN. Cytokines and mediator functions of uroepithelial cells in inflammatory reactions of urinary tract. Tsitokiny i vospalenie. 2003;2(4):1-9. (In Russ.)
12. Savel’eva VS, Gel’fanda BR. eds. Sepsis v nachale KhKh1 veka. Klassifi katsiya, klinikodiagnos cheskaya kontseptsiya i lechenie. Patologoanatomicheskaya diagnos ka: prak cheskoe rukovodstvo. M.: Li erra; 2006:1-176. (In Russ.)
13. Tsybul’kin EK. Sepsis v svete sovremennykh immunologicheskikh vozzrenii. SPb.; 2002:1-67. (In Russ.).
14. Shabanova LF, Safronov BN. Immunologicheskie issledovaniya v klinicheskoi prak ke. L.; 1986:1-32. (In Russ.).
15. Shahzad A, Knapp M, Lang I, Köhler G. Interleukin 8 (IL8) - a universal biomarker? Int Arch Med. 2010;3:11. doi: 10.1186/1755-7682-3-11
16. Mahyar A, Ayazi P, Maleki MR, Daneshi-Kohan MM, Sarokhani HR, Hashemi HJ, Talebi-Bakhshayesh M. Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children. Korean J Pediatr. 2013;56(5):218-23. doi: 10.3345/ kjp.2013.56.5.218
17. Shul’tsev GP. Voprosy k klassifikatsii pielonefritov. Kazanskii meditsinskii zhurnal. 1969;3:10-14. (In Russ.).
18. Shul’tsev GP, Burtsev VI. Mezhdunarodnyi kongress nefrologov 1976. Urologiya i nefrologiya. 1976;1:73-75. (In Russ.)
Review
For citations:
Korenkov D.G., Pavlov A.L. CYTOKINES IN THE DIAGNOSIS OF THE SEVERITY OF THE ACTIVE PHASE OF CHRONIC PYELONEPHRITIS. Urology Herald. 2017;5(3):14-21. (In Russ.) https://doi.org/10.21886/2308-6424-2017-5-3-14-21
Views:
1250
Email this article 
